SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer?
about
Sulfotransferase genetic variation: from cancer risk to treatment responseSulfotransferase 1A1 (SULT1A1) gene expression is regulated by members of the NFI transcription factors in human breast cancer cells.Pharmacogenetics of SULT1A1Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance.Quantitative analysis of the association between sulfotransferase isoform 1A1 polymorphism and risk of urothelial carcinoma.
P2860
SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer?
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
SULT1A1 rs9282861 polymorphism ...... vant therapy in breast cancer?
@ast
SULT1A1 rs9282861 polymorphism ...... vant therapy in breast cancer?
@en
SULT1A1 rs9282861 polymorphism ...... vant therapy in breast cancer?
@nl
type
label
SULT1A1 rs9282861 polymorphism ...... vant therapy in breast cancer?
@ast
SULT1A1 rs9282861 polymorphism ...... vant therapy in breast cancer?
@en
SULT1A1 rs9282861 polymorphism ...... vant therapy in breast cancer?
@nl
prefLabel
SULT1A1 rs9282861 polymorphism ...... vant therapy in breast cancer?
@ast
SULT1A1 rs9282861 polymorphism ...... vant therapy in breast cancer?
@en
SULT1A1 rs9282861 polymorphism ...... vant therapy in breast cancer?
@nl
P2860
P50
P356
P1433
P1476
SULT1A1 rs9282861 polymorphism ...... vant therapy in breast cancer?
@en
P2093
Ari Hirvonen
Maria Tengström
P2860
P2888
P356
10.1186/1471-2407-12-257
P407
P577
2012-06-18T00:00:00Z
P5875
P6179
1009126429